7/21/2010

Cubist Pharmaceuticals said its antibiotic CUBICIN has been used by 1 million patients. The drug, launched in the U.S. market in 2003, is a treatment for skin or bloodstream infection resulting from exposure to methicillin-resistant Staphylococcus aureus.

Related Summaries